IL21 and non-small cell lung carcinoma: A single-cell RNA-seq and TCR-seq analysis from IIIA non-small cell lung cancer (NSCLC) patients revealed that neoadjuvant immunotherapy combined with chemotherapy enhanced IL-21 secretion from infiltrating Tfh cells, which subsequently promoted B cell class switching and plasma cell differentiation.